| abstract |
The invention relates to inhibitors of monoamine oxidase type B (iMAO-B) for use in the treatment of pathologies or disorders associated with inflammasome activation, pharmaceutical compositions comprising said inhibitors for use thereof, medical devices comprising such compositions, and therapeutic methods for treatment of pathologies or disorders associated with inflammasome activation by administration of inhibitors of the monoamine oxidase type B enzyme. |